A population of F4/80hi monocyte‐derived cells that displays similarities to both Mφs and conventional DCs is able to efficiently cross‐present tumor Ags to CD8+ T cells.83 These cells may be similar to a previously reported monocyte‐derived DC that enters tumor‐draining lymph nodes, promotes proliferation of CD8+ T cells, and is sufficient for generating antitumoral immunity.82 The gene discussed is CD8A; the disease is neoplasm.